Cantor Fitzgerald analyst Steven Halper raised his price target for Tivity Health (TVTY) to $52 from $49 and reiterates an Overweight rating on the shares after hosting investor meetings with management. Most of the questions focused on the recently announced acquisition of Nutrisystem (NTRI), Halper tells investors in a research note. The analyst believes Nutrisystem "adds another growth component" to Tivity and that the strategy to add nutrition/weight loss to the company's offerings is logical. He finds Tivity Health shares "compelling" and believes his model assumptions are conservative and support "significantly higher" valuation levels.